Financing round brings in $20M for maker of genetic research tools

RainDance Technologies, which specializes in developing genetic research tools, secured $20 million in a Series E funding round. The Massachusetts-based firm plans to use the money to widen the reach of its products including its ThunderStorm sequencing and RainDrop digital PCR technologies. Proceeds will also go toward commercial operations and the expansion of production capacity.

View Full Article in:

Boston Herald · GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park